Although screening is effective in reducing incidence, mortality, and costs of treating colorectal cancer (CRC), it remains underutilized, in part due to limited insurance access. We used microsimulation to estimate the health and financial effects of insurance expansion and reduction scenarios in North Carolina (NC). We simulated the full lifetime of a simulated population of 3,298,265 residents age-eligible for CRC screening (ages 50-75) during a 5-year period starting January 1, 2018, including polyp incidence and progression and CRC screening, diagnosis, treatment, and mortality. Insurance scenarios included: status quo, which in NC includes access to the Health Insurance Exchange (HIE) under the Affordable Care Act (ACA); no ACA; NC Me...
Abstract Background Health care reform is changing preventive servic...
Although colorectal cancer screening is cost-effective, it requires a considerable net investment by...
Colorectal cancer (CRC) screening reduces CRC incidence and mortality but is underutilized. Effectiv...
Colorectal cancer (CRC) can be effectively prevented or detected with guideline concordant screening...
Background: Many individuals have not received recommended colorectal cancer (CRC) screening before ...
Colorectal cancer (CRC) screening rates are suboptimal, particularly among the uninsured and the und...
Few investigations have explored the potential impact of the Affordable Care Act on health disparity...
BACKGROUNDDespite clear recommendations and evidence linking colorectal cancer screening to lower in...
Colorectal cancer (CRC) fulfills the World Health Organization criteria for mass screening, but scre...
Colorectal Cancer (CRC) is the third most commonly diagnosed cancer and third leading cause of cance...
BACKGROUND The National Colorectal Cancer Roundtable, a national coalition of public, private, and v...
announced an initiative to increase colorectal cancer (CRC) screening rates in the United States to ...
Despite its demonstrated effectiveness, colorectal cancer (CRC) testing is suboptimal, particularly ...
Introduction: The Affordable Care Act (ACA) provided states and Washington D.C. the option to expand...
© Health Research and Educational Trust.Objective To determine whether, given a limited budget, a st...
Abstract Background Health care reform is changing preventive servic...
Although colorectal cancer screening is cost-effective, it requires a considerable net investment by...
Colorectal cancer (CRC) screening reduces CRC incidence and mortality but is underutilized. Effectiv...
Colorectal cancer (CRC) can be effectively prevented or detected with guideline concordant screening...
Background: Many individuals have not received recommended colorectal cancer (CRC) screening before ...
Colorectal cancer (CRC) screening rates are suboptimal, particularly among the uninsured and the und...
Few investigations have explored the potential impact of the Affordable Care Act on health disparity...
BACKGROUNDDespite clear recommendations and evidence linking colorectal cancer screening to lower in...
Colorectal cancer (CRC) fulfills the World Health Organization criteria for mass screening, but scre...
Colorectal Cancer (CRC) is the third most commonly diagnosed cancer and third leading cause of cance...
BACKGROUND The National Colorectal Cancer Roundtable, a national coalition of public, private, and v...
announced an initiative to increase colorectal cancer (CRC) screening rates in the United States to ...
Despite its demonstrated effectiveness, colorectal cancer (CRC) testing is suboptimal, particularly ...
Introduction: The Affordable Care Act (ACA) provided states and Washington D.C. the option to expand...
© Health Research and Educational Trust.Objective To determine whether, given a limited budget, a st...
Abstract Background Health care reform is changing preventive servic...
Although colorectal cancer screening is cost-effective, it requires a considerable net investment by...
Colorectal cancer (CRC) screening reduces CRC incidence and mortality but is underutilized. Effectiv...